7h agoThe FlyBEARISH 34Analyst
Archived explainer. For the current picture see today's OPY page.
Why Is OPPENHEIMER HLDGS IN A (OPY) Stock Down Today?
By the Top Tier Newswire AI Desk · September 22, 2026 at 10:30 AM ET · reviewed against 5 wire stories
OPPENHEIMER HLDGS IN A (OPY) is down -5.17% in the latest session. Our newswire has captured 5 stories on OPY across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 43/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why OPY stock is down today
Oppenheimer Holdings Inc stock fell 5.17% to $113.01 on Monday, marking a sharp decline amid a flurry of analyst activity affecting the firm’s portfolio. The drop followed multiple price target cuts on individual holdings, including Tyra Biosciences and Boston Scientific, which signaled a shift in market confidence in Oppenheimer’s stock selection. The stock opened with a modest gap down and quickly declined to a session low of $111.05 before stabilizing near $113.01.
What Happened
Oppenheimer reduced its price target for Tyra Biosciences to $40 from $50 and for Boston Scientific to $65 from $85 in the past 36 hours. These moves contributed to a broader sentiment of caution among investors. Additionally, Oppenheimer’s Brian Nagel expressed uncertainty about Nike’s near-term prospects, further amplifying concerns about the firm’s analytical stance. The stock has been under pressure in recent weeks, with a 9% drop over the past eight sessions, reflecting a broader trend of declining investor sentiment.
What The Data Shows
The stock opened at $118.39, a -0.7% gap from the prior close, and traded as low as $111.05 during the session. Volume was light at 0.0M shares, which is 0.3 times the 3-month daily average. The price trend over the past 8 sessions has been negative, with the stock falling from $123.64 to $112.56. The 52-week tape showed 1 fresh 52-week high and 11 fresh 52-week lows on the same day, indicating a mixed market reaction. The stock is currently trading within its 52-week range of $63.81 to $125.88.
What To Watch
Oppenheimer is set to report its next quarterly earnings, and investors will be watching for further signs of performance and strategic direction. Coverage breadth and analyst commentary in the coming days will be key indicators of the stock’s potential recovery.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
OPY by the numbers
Last: $113.01Session: -5.17%7 sessions: -8.96%Coverage: 5 stories / 4 sourcesAI sentiment: 43/100 (mixed)Mkt cap: $1.2BP/E: 13.252w: $63.81 to $125.88
The headlines behind the move
7h agoBusiness InsiderBULLISH 55General
Recludix Pharma to Present at the Oppenheimer Private Life Sciences Company Showcase
SAN DIEGO, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D.
1d agoCNBCNEUTRAL 50Analyst
The near term remains very uncertain for Nike, says Oppenheimer's Brian Nagel
1d agoThe FlyBEARISH 34Analyst
Boston Scientific price target lowered to $65 from $85 at Oppenheimer
2d agoYahoo TopBEARISH 42Analyst
Analyst: Meta Needs Just 115 Million Users to Ignite a $28 Billion AI Gold Rush — But It’s Not Likely to Happen
Jason Helfstein, Oppenheimer’s Managing Director and Senior Analyst covering the Internet sector, laid out a striking scenario in a September 2026 note: Meta Platforms (NASDAQ:META) would need roughly 115 million paying Muse subscribers at a $20/month price point to generate about $27.5 to $28 billion in annual AI agent revenue. His conclusion, however, was skeptical. […]
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on OPY: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier OPY move explainers: 2026-09-22